Synergistic induction of apoptosis by combination treatment with mesupron and auranofin in human breast cancer cells
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Joo-Eun | - |
dc.contributor.author | Kwon, Yeo-Jung | - |
dc.contributor.author | Baek, Hyoung-Seok | - |
dc.contributor.author | Ye, Dong-Jin | - |
dc.contributor.author | Cho, Eunah | - |
dc.contributor.author | Choi, Hyung-Kyoon | - |
dc.contributor.author | Oh, Kyung-Soo | - |
dc.contributor.author | Chun, Young-Jin | - |
dc.date.available | 2019-03-08T08:38:32Z | - |
dc.date.issued | 2017-06 | - |
dc.identifier.issn | 0253-6269 | - |
dc.identifier.issn | 1976-3786 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/4383 | - |
dc.description.abstract | Urokinase-type plasminogen activator (uPA) has been validated as a predictive or prognostic biomarker protein, and mesupron is considered the first-in-class anticancer agent to inhibit uPA activity in human breast cancer. In the present study, we showed that the synergism between mesupron and auranofin, a thioredoxin reductase inhibitor, for inducing of apoptosis in MCF-7 human breast cancer cells. Our results demonstrated that mesupron and auranofin significantly lead to inhibition of the cancer cells proliferation; cell cycle arrest at the G1/S phase of the cell cycle, and apoptosis as indicated by caspase 3 activation, poly(ADP-ribose) polymerase cleavage, and annexin V staining. Isobologram analyses of MCF-7 cells showed a clear synergism between mesupron and auranofin. This combined treatment decreased the levels of mitochondrial anti-apoptotic factors, such as BCL-2, BCL-xL, and MCL-1 and caused nuclear translocation of apoptosis-inducing factor. Mitochondrial membrane potential (Delta psi(m) ) was found to be strongly disrupted in combination-treated cells. In addition, combination treatment significantly enhanced the overproduction of reactive oxygen species, which was rescued by N-acetylcysteine treatment. The combination treatment suppressed phosphorylation of Akt, thus contributing to apoptosis. Taken together, our data suggest that the use of mesupron in combination with auranofin may be important in achieving high anticancer synergy. | - |
dc.format.extent | 14 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | PHARMACEUTICAL SOC KOREA | - |
dc.title | Synergistic induction of apoptosis by combination treatment with mesupron and auranofin in human breast cancer cells | - |
dc.type | Article | - |
dc.identifier.doi | 10.1007/s12272-017-0923-0 | - |
dc.identifier.bibliographicCitation | ARCHIVES OF PHARMACAL RESEARCH, v.40, no.6, pp 746 - 759 | - |
dc.identifier.kciid | ART002231491 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000404167800009 | - |
dc.identifier.scopusid | 2-s2.0-85019741417 | - |
dc.citation.endPage | 759 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 746 | - |
dc.citation.title | ARCHIVES OF PHARMACAL RESEARCH | - |
dc.citation.volume | 40 | - |
dc.type.docType | Article | - |
dc.publisher.location | 대한민국 | - |
dc.subject.keywordAuthor | Auranofin | - |
dc.subject.keywordAuthor | Mesupron | - |
dc.subject.keywordAuthor | Apoptosis | - |
dc.subject.keywordAuthor | Synergism | - |
dc.subject.keywordAuthor | ROS | - |
dc.subject.keywordAuthor | AIF | - |
dc.subject.keywordPlus | ANTIRHEUMATIC AGENT AURANOFIN | - |
dc.subject.keywordPlus | PLASMINOGEN-ACTIVATOR UPA | - |
dc.subject.keywordPlus | ROS-MEDIATED MECHANISMS | - |
dc.subject.keywordPlus | THIOREDOXIN REDUCTASE | - |
dc.subject.keywordPlus | MITOCHONDRIAL DYSFUNCTION | - |
dc.subject.keywordPlus | LUNG-CANCER | - |
dc.subject.keywordPlus | IN-VITRO | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordPlus | INHIBITOR | - |
dc.subject.keywordPlus | STRESS | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.